Total planned funding: $47,261,719
Clear active filters
Democratic Republic of the Congo
HTXD: Treatment: ARV Drugs
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Democratic Republic of the Congo | $47,261,719 |
Organizational Types
Private Contractor | $46,899,171 |
Own Agency | $249,347 |
NGO | $87,500 |
Unknown | $19,116 |
Other USG Agency | $6,585 |
FBO | $0 |
Multi-lateral Agency | $0 |
University | $0 |
Program Areas
Treatment | $47,261,719 |
Budget Codes
HTXD: Treatment: ARV Drugs | $47,261,719 |
Top Partner Programs
Chemonics International:
$46,899,171
Countries/Regions
Democratic Republic of the Congo
2017 | $13,616,299 |
2018 | $11,556,778 |
2019 | $21,726,094 |
USG Aggregated Agencies:
$184,987
Countries/Regions
Democratic Republic of the Congo
2017 | $69,739 |
2018 | $115,248 |
IntraHealth International, Inc.:
$87,500
Countries/Regions
Democratic Republic of the Congo
2019 | $87,500 |